These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2992617)

  • 21. Dexamethasone suppression test in geriatric depression.
    Alexopoulos GS; Young RC; Kocsis JH; Brockner N; Butler TA; Stokes PE
    Biol Psychiatry; 1984 Nov; 19(11):1567-71. PubMed ID: 6518207
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preliminary study of the dexamethasone suppression test in endogenous depression].
    Omori T; Denda K; Koyama T; Matsubara S; Yasuda M
    Seishin Shinkeigaku Zasshi; 1983; 85(11):816-9. PubMed ID: 6677917
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical significance of the diagnostic use and assay of corticotropin-releasing hormone in the physiopathologic state of the hypothalamo-pituitary-adrenal axis].
    Nishikawa T; Yoshida A; Mikami K; Tamura Y; Yoshida S
    Nihon Rinsho; 1990 Feb; 48 Suppl():182-4. PubMed ID: 2162415
    [No Abstract]   [Full Text] [Related]  

  • 24. The stress hormone system is back on the map.
    Holsboer F
    Curr Psychiatry Rep; 2000 Dec; 2(6):454-6. PubMed ID: 11122996
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.
    Pasquali R; Anconetani B; Chattat R; Biscotti M; Spinucci G; Casimirri F; Vicennati V; Carcello A; Labate AM
    Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasopressin, major depression, and hypothalamic-pituitary-adrenocortical desensitization.
    Müller MB; Landgraf R; Keck ME
    Biol Psychiatry; 2000 Aug; 48(4):330-3. PubMed ID: 10960167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
    Zis AP; Haskett RF; Albala AA; Carroll BJ; Lohr NE
    Arch Gen Psychiatry; 1985 Apr; 42(4):383-6. PubMed ID: 3977556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothalamo-pituitary-adrenal axis testing: nothing is sacred and caution in interpretation is needed.
    Dickstein G
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):15-6. PubMed ID: 11167920
    [No Abstract]   [Full Text] [Related]  

  • 29. The HPA axis response to insulin hypoglycemia in depression.
    Lopez JF; Kathol RG; Jaeckle RS; Meller W
    Biol Psychiatry; 1987 Feb; 22(2):153-66. PubMed ID: 3028510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma immunoreactive beta-endorphin in dexamethasone suppressors and non-suppressors of cortisol.
    Norman TR; Piperoglou M; McIntyre IM; Lynch C; Burrows GD
    J Affect Disord; 1987; 12(3):233-9. PubMed ID: 3038984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder.
    Yehuda R; Giller EL; Southwick SM; Lowy MT; Mason JW
    Biol Psychiatry; 1991 Nov; 30(10):1031-48. PubMed ID: 1661614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship of dexamethasone suppression to psychological test variables.
    Danahy SA; Schwartz BD; Willard SG; Winstead DK
    J La State Med Soc; 1986 Jan; 138(1):38-43. PubMed ID: 3950587
    [No Abstract]   [Full Text] [Related]  

  • 34. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K; Rybakowski J
    Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research.
    Stetler C; Miller GE
    Psychosom Med; 2011; 73(2):114-26. PubMed ID: 21257974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression.
    O'Toole SM; Sekula LK; Rubin RT
    Biol Psychiatry; 1997 Jul; 42(2):85-9. PubMed ID: 9209724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B; Sherman B; Schlechte J; Stone R
    Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is conversion disorder biologically related with depression?: a DST study.
    Tunca Z; Fidaner H; Cimilli C; Kaya N; Biber B; Yeşil S; Ozerdem A
    Biol Psychiatry; 1996 Feb; 39(3):216-9. PubMed ID: 8837984
    [No Abstract]   [Full Text] [Related]  

  • 39. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of treatment on plasma cortisol and dexamethasone.
    Carson SW; Halbreich U
    Biol Psychiatry; 1987 Feb; 22(2):213-6. PubMed ID: 3814671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.